Related Experiment Videos
INGAP-related pentadecapeptide: its modulatory effect upon insulin secretion
María I Borelli1, Luiz F Stoppiglia, Luiz F Rezende
1CENEXA-Center of Experimental and Applied Endocrinology (UNLP-CONICET, PAHO/WHO Collaborating Center), National University of La Plata School of Medicine, La Plata, Argentina.
Regulatory Peptides
|August 9, 2005
Summary
The islet neogenesis-associated protein-derived peptide (INGAP-PP) significantly boosts insulin secretion from both adult and neonatal rat islets. This peptide also increases beta-cell size, offering potential for enhancing islet function.
Area of Science:
- Endocrinology
- Cell Biology
- Metabolic Research
Background:
- Pancreatic islets are crucial for glucose homeostasis, producing insulin.
- Beta-cell function and mass are key targets for diabetes research.
- Islet neogenesis-associated protein (INGAP) plays a role in islet development.
Purpose of the Study:
- To investigate the effects of a specific INGAP peptide (INGAP-PP) on insulin secretion and islet morphology.
- To determine if INGAP-PP enhances glucose- and amino acid-stimulated insulin release.
- To assess the impact of INGAP-PP on beta-cell size and islet cell survival.
Main Methods:
- Culturing adult and neonatal rat pancreatic islets in varying concentrations of INGAP-PP.
- Measuring insulin release in response to glucose and amino acids.
- Utilizing a scrambled peptide as a control for specificity.
- Assessing islet cell survival and beta-cell morphology.
Main Results:
- INGAP-PP significantly enhanced glucose- and amino acid-induced insulin release in both adult and neonatal islets.
- The effects were specific to INGAP-PP, as a scrambled peptide showed no impact.
- INGAP-PP significantly increased beta-cell size without affecting islet survival or cell proportion.
- Adult islets exhibited a greater insulin response compared to neonatal islets.
Conclusions:
- INGAP-PP demonstrates a potent ability to enhance the secretory capacity of pancreatic beta-cells.
- This peptide represents a novel therapeutic avenue for increasing islet function in conditions like diabetes.
- Further research into INGAP-PP's production and application in vivo is warranted.